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Abstract: Despite the importance of n-3 fatty acids for health, intakes remain below recommended
levels. The objective of this study was to provide an updated assessment of fish and n-3 fatty
acid intake (i.e., eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and EPA+DHA) in the
United States using the 2003–2014 National Health and Nutrition Examination Survey (NHANES)
data (n = 45,347)). Over this survey period, toddlers, children, and adolescents (aged 1–19) had
significantly lower n-3 fatty acid intake (p < 0.001) compared to adults and seniors, which remained
significant after adjusting for caloric intake. Females demonstrated lower n-3 fatty acid intake than
males (p < 0.001), with adult and senior women having significantly lower intakes compared to men
in the same age categories (p < 0.001) after adjustment for energy intake. Women also consumed less
fish than men (5.8 versus 6.1 servings/month, p < 0.001). The estimated intakes of n-3 fatty acids in
pregnant women did not differ from non-pregnant women (p = 0.6 for EPA+DHA), although pregnant
women reported consuming less high n-3 fatty acid-containing fish than non-pregnant women (1.8
versus 2.6 servings/month, p < 0.001). Our findings indicate that subgroups of the population may
be at higher risk of n-3 fatty acid intakes below recommended levels.
Keywords: eicosapentaenoic acid; docosahexaenoic acid; omega-3 fatty acids; lifespan; oily fish; fish
oil supplements
1. Introduction
The major n-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA), play key physiological roles related to health and disease, and the health benefits of n-3
fatty acids are well established [1–9]. Intake of fatty fish is the primary contributor of EPA and DHA
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in the diet, with α-linolenic acid (ALA) conversion serving as an additional, but limited, source [10].
Supplementation with fish, krill, and cod liver oils, as well as other products derived from algal sources
can also improve n-3 fatty acid status [11].
The health benefits conferred by n-3 fatty acids are important throughout the lifespan. In early
life, n-3 fatty acids play an essential role in growth and development, including development of the
eyes and brain [12]. Increased intake of n-3 fatty acids during pregnancy has been associated with
decreased maternal depression [13], reduced rates of intrauterine growth restriction [12], preterm
birth [12,14,15], reduced allergies and asthma in children [16,17], and improved neurocognitive
outcomes in offspring [13]. In adults, higher consumption of n-3 fatty acids has been associated
with cardio-protective effects such as anti-hyperlipidemia, anti-thrombotic, anti-inflammatory,
anti-hypertensive, and anti-arrhythmic effects [8,18]. However, n-3 fatty acid intake in the Western
diet is typically low compared to recommended intakes [14,15].
Furthermore, despite the health benefits associated with n-3 fatty acid intake during distinct life
stages, gaps in knowledge remain with regard to how n-3 fatty acid intake differs by age and/or gender
in representative samples of the US population. For instance, a recent study found that only 14.1%
of children aged 7–12 years met the National Academy of Medicine (NAM; formerly known as the
Institute of Medicine (IOM)) recommendations for DHA and EPA intake for their age and gender [19].
Similarly, a study performed in Australia demonstrated that adolescents (12–17 years of age) continued
to fall below Australian National Heart Foundation recommended intakes (≥500 mg/day EPA+DHA)
despite significant increases in intake that occurred with age [20]. Evidence regarding n-3 fatty acid
intake in early childhood is also lacking, which has particularly important developmental implications.
Previous research has also provided preliminary insights into n-3 fatty acid intake in other
subgroups of the total population. With regard to pregnancy, our previous analysis of the National
Health and Nutrition Examination Survey (NHANES) data from 2003–2012 demonstrated that
pregnant women and women of childbearing age have lower intakes of n-3 fatty acids compared
to males of the same age [21]. A subsequent NHANES analysis using data from 2001–2014 found
that 100% of childbearing-age women and pregnant women did not meet the 8 ounce/week seafood
consumption recommendation in the 2015–2020 Dietary Guidelines for Americans, with over 95% of
women in this age range not meeting the EPA+DHA intake recommendation of 250 mg/day [22].
In order to identify subgroups of the US population at risk of low omega-3 fatty acid intake,
the objective of this study was to assess current n-3 fatty acid intake in subgroups of the US population
and evaluate differences based on age, gender, and pregnancy status using NHANES data as a
nationally representative sample. Fish intake and supplement use were also analyzed in these groups.
2. Materials and Methods
NHANES is a cross-sectional survey conducted by the National Center for Health Statistics
(NCHS), under the Centers for Disease Control and Prevention, using a complex multistage probability
sample that is designed to be representative of the national civilian US population [23]. Sampling
weights were adjusted to account for multiple cycles. Males and females aged 1 year or older were
included. Adult men with caloric intakes of <800 kcal or >8000 kcal per day and adult women with
caloric intakes of <600 kcal or >6000 kcal per day were excluded. Daily intakes of the long-chain n-3
fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were calculated for the total
US population and the following age groups: toddler/early childhood (1–5 years), middle childhood
(6–11 years), adolescents (12–19 years), adults (20–55 years) and seniors (55+ years). Each age group
was also analyzed by gender.
Population mean daily intakes of EPA and DHA are reported from two averaged 24-h dietary
recall interviews from each participant. Trained dietary interviewers collected detailed information
on all foods and beverages consumed by respondents in the previous 24-h time period (midnight to
midnight). A second dietary recall was administered by telephone 3 to 10 days after the first dietary
interview, but not on the same day of the week as the first interview. If an individual did not complete
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the second dietary interview, only the first dietary interview was used for the EPA and DHA intake
from food.
Participants were also asked if they had taken a dietary supplement in the past 30 days, how long
they had been taking it, how many days it was taken in the past 30 days, the amount that was taken on
those days, and the reason(s) that they were taking it. Label information, such as supplement name,
manufacturer and/or distributor, serving size, form of serving size, and ingredients, were recorded
for each supplement reported by participants. For each supplement, the amount of EPA and DHA
provided was obtained from the supplement label. When the EPA and DHA content was not specified
on the supplement label, the EPA and DHA content was imputed based on the proportion of EPA
and DHA in the n-3 fatty acid-containing ingredient (i.e., 18% EPA and 12% DHA per 1 g of fish oil;
8% EPA and 10% DHA per 1 g of cod liver oil; and 8% EPA and 12% DHA per 1 g of salmon oil).
Only supplements containing fish oil, cod liver oil, salmon oil, krill oil, and DHA-only preparations
were included.
Total fish intake in the last 30 days was calculated based on the number of times a respondent
reported eating each of the 31 types of fish included in the NHANES survey over the last 30 days. If an
individual answered “No” for eating a particular fish, the number of times that particular fish was
consumed in the last 30 days was assumed to be zero. Additionally, intake of fish high in n-3 fatty
acids was calculated using the above described method but limited to 7 fish (tuna, mackerel, salmon,
sardines, shark, swordfish, and trout).
Descriptive statistics (counts and percentages, means and standard errors and confidence intervals)
are shown for all participants. SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) was used for
all statistical analyses. SURVEYFREQ, SURVEYMEANS, and SURVEYREG were used to compute
descriptive statistics and regression analyses as these procedures account for complex survey design
and sampling weight. The Rao–Scott chi-square test was used to assess the association between
categorical variables. Continuous variables were compared using regression analysis (SURVEYREG).
All comparisons included an adjustment for energy intake. Pairwise comparisons between groups
were adjusted for multiple comparisons using the Bonferroni method. Significance was set at p < 0.05.
When assessing differences between IOM/World Health Organization (WHO) and NHANES age
groups, the recommended intakes for the age groups of interest were averaged to use as a reference
with the observed NHANES data. For example, in comparing our early childhood age group (1–5 year)
with IOM recommendations, we utilized 150 mg/day as an average of the suggested intakes for the 2–4
years (100–150 mg/day) and 4–6 years (150–200 mg/day) WHO age classifications. Further, the IOM
does not give direct recommendations for EPA+DHA; instead the IOM recommends 10% of the total
dietary intake of n-3 fatty acids comes from EPA+DHA.
3. Results
3.1. Participant Characteristics
Participant characteristics (n = 45,347) are provided in Table 1, including average EPA, DHA,
and EPA+DHA intakes across survey participants/subgroups and the number of participants included
in each subgroup.
3.2. EPA and DHA Intake by Age, Gender, and Pregnancy Status
EPA and DHA intake by age group is shown in Table 2. Adults and seniors had significantly
higher intakes of EPA, DHA, and EPA+DHA per 1000 kcal (53.5 mg EPA+DHA per 1000 kcal and
66.7 mg EPA+DHA per 1000 kcal, respectively) compared to adolescents (29.7 mg EPA+DHA per
1000 kcal; p < 0.001). EPA+DHA intake adjusted for caloric intake (mg EPA+DHA per 1000 kcal)
was higher in adolescents compared to toddlers/early childhood (23.1 mg EPA+DHA per 1000 kcal;
p < 0.001). Adults and seniors had equivalent intake (p = 1.0) of EPA and DHA, as well as their
combination per 1000 kcal. Regarding gender, intake of EPA, DHA, and combined EPA+DHA was
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significantly higher in males than females, overall and within each age group, (p < 0.001 for all n-3 fatty
acids/combinations) with intake by men of all age groups being consistently higher than females of the
same age group (Table 3). There were no significant differences in EPA, DHA, or EPA+DHA intake in
pregnant women compared to non-pregnant women of childbearing age (100.6 vs. 92.7 mg EPA+DHA
in pregnant versus non-pregnant women aged 20–44 years; Table 4). Together, these data indicate
significant differences in n-3 fatty acid consumption across age subgroups for the years surveyed,
suggesting that younger individuals may be at risk for low n-3 fatty acid intake. Furthermore, women
may be at particular risk for low n-3 fatty acid intake compared to men.
Table 1. Descriptive characteristics of the National Health and Nutrition Examination Survey
(NHANES) study population (n = 45,347).
Characteristics n Mean (SE 1)
Age (years) 45,347 37.2 (0.3)
EPA 2 intake (mg) 45,244 32.6 (1.0)
DHA 3 intake (mg) 45,244 64.4 (1.5)
EPA+DHA intake (mg) 45,244 96.9 (2.5)
Total fish intake (servings/month) 33,403 6.5 (0.1)
Fish high in n-3 intake (servings/month) 18,562 2.5 (0.1)
(%)
Gender Male 22,056 48.5
Female 23,291 51.5
Pregnant Yes 762 4.8
No 8381 92.1
Do not know 287 3.1
Age group Toddler/Early Childhood (1–5 years) 5495 6.9
Middle Childhood (6–11 years) 5550 8.3
Adolescent (12–19 years) 8186 11.5
Adult (20–55 years) 15,937 50.2
Seniors (55+ years) 10,179 23.1
1 SE, standard error; 2 EPA, eicosapentaenoic acid; 3 DHA, docosahexaenoic acid.
Table 2. n-3 fatty acid (mg) per 1000 kcal intake by age group 1.
Age Group Variable n Mean (SE 2), mg 95% CI for Mean
Toddler/Early Childhood
1–5 years
EPA 5392 6.9 (0.4) 6.2, 7.7
DHA 5392 16.1 (0.6) 14.9, 17.4
EPA+DHA 5392 23.1 (1.0) 21.1, 25.0
Middle Childhood
6–11 years
EPA 5550 8.4 (0.5) 7.4, 9.4
DHA 5550 17.5 (0.9) 15.7, 19.2
EPA+DHA 5550 25.9 (1.4) 23.1, 28.6
Adolescents
12–19 years
EPA 8186 9.9 (0.6) 8.8, 11.0
DHA 8186 19.8 (0.9) 18.0, 21.5
EPA+DHA 8186 29.7 (1.4) 26.9, 32.5
Adults
20–55 years
EPA 15,937 17.9 (0.6) 16.7, 19.1
DHA 15,937 35.4 (0.9) 33.5, 37.2
EPA+DHA 15,937 53.3 (1.5) 50.3, 56.3
Seniors
55 years & above
EPA 10,179 22.4 (0.9) 20.6, 24.2
DHA 10,179 44.3 (1.6) 41.0, 47.5
EPA+DHA 10,179 66.7 (2.5) 61.7, 71.7
1 p-value < 0.001 for EPA, DHA, and EPA+DHA intake between age groups adjusted for energy intake. 2 SE,
standard error.
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Table 3. n-3 fatty acid intake (mg) per 1000 kcal by gender and age subgroup.
Gender Variable
Adolescents
12–19 years
Adults
20–55 years
Seniors
55+ years
p-Value
(n = 8203) (n = 16,215) (n = 10,475)
Mean (SE 1), mg Mean (SE 1), mg Mean (SE 1), mg
Male
EPA 9.3 (0.6) 17.6 (0.7) 22.2 (1.3) <0.001
DHA 19.1 (1.0) 34.6 (1.0) 43.7 (2.5) <0.001
EPA+DHA 28.4 (1.6) 52.1 (1.7) 65.9 (3.8) <0.001
Female
EPA 10.5 (0.8) 18.3 (0.9) 22.5 (1.3) <0.001
DHA 20.4 (1.1) 36.1 (1.5) 44.8 (2.0) <0.001
EPA+DHA 31.0 (1.8) 54.4 (2.4) 67.3 (3.2) <0.001
1 SE, standard error.
Table 4. n-3 fatty acid intake by pregnancy status.
Pregnant Women 1 Non-Pregnant Women
p-Value(n = 762, 8.3%) (n = 8381, 91.7%)
Mean (SE 2), mg Mean (SE 2), mg
EPA 33.1 (4.1) 31.6 (1.9) 0.76
DHA 67.5 (11.8) 61.1 (2.8) 0.60
EPA+DHA 100.6 (15.2) 92.7 (4.7) 0.63
1 Pregnancy status applied to women of age 20–44; 287 women had no status; 2 SE, standard error.
3.3. Fish Intake by Age Group, Gender, and Pregnancy Status
Intakes of total and high n-3 fatty acid-containing fish over a 30-day period are presented
in Table 5, based on age group, gender, and pregnancy status. Similar to our findings for total
EPA, DHA, and EPA+DHA intake, there was a significant difference in the intake of total fish and
fish high in n-3 fatty acids based on age. Pairwise comparisons identified that adults and seniors
consumed significantly more total fish (6.5 servings/month for both) and fish high in n-3 fatty acids
(2.6 servings/month for both) compared to the toddler/early childhood (4 and 1.5 servings/month,
respectively), middle childhood (3.8 and 1.5 servings/month, respectively), and adolescent age groups
(3.9 and 1.6 servings/month, respectively; p < 0.001 for all comparisons). Intake of total and n-3 fatty
acid-rich fish did not differ significantly amongst the adolescent, middle childhood, or toddler/early
childhood groups, nor did it differ between the adults and seniors. These findings concur with the
24-h dietary recall findings indicating significantly lower consumption of n-3 fatty acid-containing
foods (i.e., fish) by younger individuals.
Differences in fish consumption by age also remained when comparing male and female age
subgroups (Table 6). Overall, males consumed approximately 5% more servings of total fish compared
to females (6.1 vs. 5.8 servings of total fish/month, respectively; p < 0.001), whereas women
consumed about 4% more servings per month of fish high in n-3 fatty acids than men (2.4 vs. 2.3
servings/month, respectively; p = 0.006). When comparing pregnant women versus non-pregnant
women of childbearing age (Table 5), pregnant women reported consuming 1.8 servings/month of
high n-3 fatty acid-containing fish, which was significantly lower than the 2.6 servings/month reported
by non-pregnant women (p < 0.001). Findings were similarly lower for total fish intake in pregnant
women compared to women of childbearing age. These results further corroborate the findings of
our analysis of the 24-h dietary recall data, whereby younger individuals and females report lower
consumption of n-3 fatty acid-containing foods (i.e., fish) compared to older individuals and men.
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Table 5. Total fish intake (servings/month) and intake of fish high in n-3 fatty acids for a 30-day period.
Total Fish High n-3 Fish
n Mean (SE 1) 95% CI p-Value n Mean (SE 1) 95% CI p-Value
Age Group
Toddler/Early Childhood 4040 4 (0.1) (3.7, 4.2) 3427 1.5 (0.1) (1.3, 1.6)
Middle Childhood 3514 3.8 (0.1) (3.6, 4.1) 2859 1.5 (0.1) (1.3, 1.7)
Adolescent 4608 3.9 (0.1) (3.6, 4.2) 3344 1.6 (0.1) (1.4, 1.8)
Adult 13,395 6.5 (0.1) (6.2, 6.7) 11,584 2.6 (0.1) (2.5, 2.7)
Senior 7846 6.5 (0.1) (6.2, 6.8) <0.001 7348 2.6 (0.1) (2.4, 2.7) <0.001
Gender
Male 15,829 6.1 (0.1) (5.8, 6.4) 13,519 2.3 (0.1) (2.2, 2.5)
Female 17,574 5.8 (0.1) (5.6, 6) <0.001 15,043 2.4 (0.1) (2.3, 2.6) 0.006
Pregnant
Yes 630 4.6 (0.2) (4.1, 5.1) 511 1.8 (0.2) (1.4, 2.1)
No 6276 6.1 (0.1) (5.8, 6.4) 5279 2.6 (0.1) (2.4, 2.8)
Cannot Determine 171 5.9 (0.7) (4.6, 7.2) <0.001 141 2.6 (0.3) (2.1, 3.2) <0.001
1 SE, standard error.
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Table 6. Fish intake by age in males and females over a 30-day period.
Male Female
n Mean (SE 1) 95% CI p-Value n Mean (SE 1) 95% CI p-Value
Total Fish
Adolescent 2182 3.9 (0.2) (3.6, 4.3) 2426 3.9 (0.2) (3.5, 4.2)
Adult 5994 6.8 (0.2) (6.4, 7.1) 7401 6.2 (0.1) (5.9, 6.5)
Senior 3865 6.7 (0.2) (6.4, 7.1) <0.001 3981 6.3 (0.2) (6, 6.6) <0.001
High n-3 Fish
Adolescent 1599 1.5 (0.1) (1.3, 1.7) 1745 1.6 (0.1) (1.4, 1.9)
Adult 5160 2.7 (0.1) (2.5, 2.8) 6424 2.6 (0.1) (2.4, 2.7)
Senior 3597 2.4 (0.1) (2.2, 2.6) <0.001 3751 2.8 (0.1) (2.6, 3) <0.001
1 SE, standard error.
3.4. EPA/DHA-Containing Supplement Use by Age, Gender, and Pregnancy Status
The total percentage of participants taking EPA/DHA-containing supplements was 0.8% (Table 7).
EPA, DHA, and combined EPA+DHA intake was significantly higher in individuals reporting use
of any supplement (with or without n-3 fatty acids) compared to individuals who did not report
supplement use (Table 8; p < 0.001). Individuals taking an EPA/DHA-containing supplement had
significantly elevated intake compared to individuals not taking n-3 fatty acid-containing supplements
or not reporting any supplement use (Table 8; p < 0.001). While 0.6% of childbearing-age women
reported taking an EPA/DHA-containing supplement, 7.3% of pregnant women reported use of
EPA/DHA-containing supplements. As supplement use is associated with increased n-3 fatty acid
intake, supplementation could be an important source of EPA/DHA, particularly for pregnant women
given their lower fish consumption compared to non-pregnant women of childbearing age.
Table 7. Proportion of participants taking a supplement containing EPA/DHA.
Reported EPA/DHA Supplement Use (%)
Total Population 328 (0.8)
Age
Toddler/Early Childhood 26 (0.5)
Middle Childhood 36 (0.6)
Adolescent 26 (0.4)
Adult 139 (0.9)
Senior 101 (1.0)
Gender
Male 177 (0.8)
Female 151 (0.8)
Pregnant
Yes 23 (7.3)
No 41 (0.6)
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Table 8. EPA/DHA intake categorized by supplement use.
EPA DHA
Mean (SE 1), mg 95% CI p-Value Mean (SE 1), mg 95% CI p-Value
Total Population
Without supplement information 32.6 (1.0) 30.7, 34.5 64.4 (1.6) 61.3, 67.4
With supplement information 33.9 (1.0) 32.0, 35.9 <0.001 65.7 (1.6) 62.6, 68.8 <0.001
By Supplement Type
Supplement with n-3 207.6 (16.1) 175.6, 239.7 240.1 (11.9) 216.5, 263.8
Supplement w/o n-3 35.1 (1.3) 32.5, 37.8 68.8 (2.2) 64.5, 73.1
Does not take supplement 29.7 (1.0) 27.6, 31.7 <0.001 59.3 (1.5) 56.2, 62.3 <0.001
1 SE, standard error.
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4. Discussion
Our analysis of the NHANES 2003–2014 data demonstrates that there are significant differences
in EPA and DHA intake based on age, gender, and pregnancy status, with potentially vulnerable
populations (i.e., children and women) consuming amounts that are well below recommended intake
levels. Overall, intake of EPA, DHA, EPA+DHA, and fish intake (both total and n-3 fatty acid-rich
fish) increased with age. Only 0.8% of the study population reported using EPA/DHA supplements,
but this was associated with a significantly higher EPA, DHA, and EPA+DHA intake compared
to non-supplement users; thus, EPA/DHA supplements may provide a potential alternative or
complement to dietary sources (e.g., cold-water fatty fish such as salmon, mackerel, tuna, herring,
and sardines) and an effective means of increasing n-3 fatty acid intake. Current recommendations for
daily n-3 fatty acid intake vary widely and recommended daily allowances or dietary reference intakes
have not been set for DHA and EPA across age groups. However, numerous groups have issued
recommendations for adequate intake (AI) of n-3 fatty acids based on age, health, and other factors
(Table 9). In our analysis, all groups across age, gender, and pregnancy status failed to meet these
recommended intakes for EPA, DHA, and EPA+DHA, putting vulnerable populations at potential risk
for adverse health outcomes.
Table 9. n-3 fatty acid dietary reference intakes.
World Health Organization [24]
Age Adequate Intake (AI):
DHA 12–24 months 10–12 mg/kg
EPA+DHA 2–4 years 100–150 mg
4–6 years 150–200 mg
6–10 years 200–250 mg
Adults 200–500 mg
National Institute of Medicine [11]
Age Male/Female as (mg/day)
EPA+DHA *
1–3 years 70 mg/70 mg
4–8 years 90 mg/90 mg
9–13 years 120 mg/100 mg
14–18 years 160 mg/110 mg
19–50 years 160 mg/110 mg
51+ years 160 mg/110 mg
Workshop on the Essentiality of and
Recommended Dietary Intakes for n-6
and n-3 fatty acids ** [25]
Adult intake based on a 2000
kcal diet
DHA 220 mg/day
EPA 220 mg/day
EPA+DHA 650 mg/day
Pregnancy and Lactation
DHA 300 mg/day
EPA 220 mg/day
American Heart Association
Adults [26]
• Eat at least 8 oz of fish/week
(equal to 2 servings/week
U.S. Dept of Agriculture and U.S.
Department of Health and Human
Services [27]
Adults
Increase the amount and variety
of seafood consumed, in place of
some meat and poultry
Pregnant or Breastfeeding Women
Consume at least 8 and up to 12
ounces per week of a variety
of seafood
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Table 9. Cont.
FDA [28]
For women of childbearing age (approximately 16–49 years old),
especially pregnant and breastfeeding women, and for parents and
caregivers of young children.
• Eat 2 to 3 servings of fish a week from the “Best Choice” list (i.e.,
herring, shrimp, tilapia) OR 1 serving from the “Good Choice”
list (i.e., snapper, halibut, Mahi mahi).
• Eat a variety of fish.
• Serve 1 to 2 servings of fish a week to children, starting at age 2.
The American College of Obstetricians
and Gynecologist [29]
• Eat at least 2 servings of fish or shellfish (8–12 oz) per week before
becoming pregnant, while pregnant, and while breastfeeding.
* The National Institute of Medicine suggests 10% of ALA intake be from EPA+DHA, with no specific intake
recommendations for EPA or DHA. Values in this table were calculated from recommended ALA values.
** Workshop sponsored by National Institute on Alcohol Abuse and Alcoholism-NIH, the Office of Dietary
Supplements-NIH, The Center for Genetics, Nutrition and Health, and the International Society for the Study of
Fatty Acids and Lipids.
Although the lack of standardized recommendations makes direct comparisons challenging,
results consistently indicate that individuals from 1–19 years of age have low n-3 fatty acid intakes.
Low n-3 fatty acid intake during this stage of life has significant implications given the role of these
fatty acids in the development of the central nervous system and retina [12]. Pre- and postnatal intake
of n-3 fatty acids in infants has been associated with improved neurocognitive outcomes [13], higher
birth weights and lengths [30–32]. In early childhood, n-3 fatty acids are a part of maintenance and
cell turnover throughout the body and have been shown to have a positive impact on brain activity,
learning and cognition [27–29,33]. In children 1–5 years old, we found that total EPA+DHA intake
(32.4 mg/day or 23.1 mg per 1000 kcal) reached only ~40% of the EPA+DHA intake recommended
by the IOM for age groups 1–3 years (70 mg/day) and 4–8 years (90 mg/day). When compared to
the WHO recommendations, the toddler/early childhood age group reached less than one-quarter
of the recommended intake of ~150 mg/day. This corroborates findings from a 2013 study in which
toddlers aged 13–24 months had inadequate intake of n-3 fatty acids according to IOM dietary
recommendations [34]. Children aged 6–11 years old also demonstrated low intakes of n-3 fatty
acids according to the IOM and WHO recommendations with EPA+DHA intakes (47.6 mg/day or
25.9 mg per 1000 kcal) ranging from ~4.5–27% of the IOM’s (950–1050 mg) and WHO’s (175–225 mg)
recommended daily intakes, respectively. Similar results were found in the Southeastern United States,
where only 14.1% of children aged 7–12 years reached IOM recommendations for EPA and DHA [19].
Adolescents (12–19 years) likewise had low n-3 fatty acid intake (59.2 mg/day EPA+DHA or 29.7 mg per
1000 kcal), reaching approximately 50% of the IOM recommendation for ages 14–18 years (160 mg/day
for males and 110 mg/day for females) and falling well short of the WHO recommendation for all
ages past 10 years (200–500 mg/day). Similarly, Gopinath et al. found that mean n-3 fatty acid intake
remained low in adolescents aged 12 to 16 years old when compared to younger ages, despite a
significant increase in energy-adjusted dietary intake of total n-3 fatty acids, EPA, and DHA [20].
The importance of n-3 fatty acids extends long past childhood as they also have vital physiological
roles in adulthood and advanced age. For instance, eicosanoids and other bioactive lipid mediators
derived from n-3 fatty acid metabolism are signaling molecules that have a variety of functions in the
cardiovascular, pulmonary, immune and endocrine systems [35,36]. With regard to cardiovascular
disease risk factors, there is strong evidence that n-3 fatty acids can beneficially modify blood lipids,
inflammation, and endothelial function [2]. In older adults (55+ years old), n-3 fatty acids have
also been shown to help modulate depression and cognitive decline [37]. Although adults and
seniors had the highest EPA+DHA intakes in our study, they still fell well below recommended levels
(Table 9). For instance, EPA+DHA intake in adults and seniors (53.3 and 66.7 mg/day per 1000 kcal,
respectively) reached only 16% and 21% of the 325 mg/day per 1000 kcal minimum recommendation
from the Workshop on the Essentiality of and Recommended Dietary Intake. Using the minimum
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recommendation of 200 mg/day of EPA+DHA given by many organizations, mean intake by adults and
seniors in our study (with unadjusted daily intakes of 112.5 mg and 118.5 mg EPA+DHA, respectively)
met less than 60% of the intake recommendation.
Despite the distinct functional roles n-3 fatty acids play across the lifespan, most recommendations
do not address older adults specifically. Although adolescent and elderly brains experience different
changes, the IOM classifies these two populations together and recommends the same n-3 fatty
acid intakes for ages 14–55+ years. Similarly, most organizations do not make a distinction
between adults and seniors, despite known age-related changes in the elderly, and provide the
same recommendations for 19–51+ years. Additional research evaluating the potential differing
n-3 fatty acid physiological requirements across these age groups is needed for the development of
evidence-based recommendations and may have implications for modulating risk factors to protect
against chronic disease.
Gender and age disparities may also exist for n-3 fatty acid intake. In our analysis, men reported
significantly higher n-3 fatty acid intake compared to women. In both men and women, adults and
seniors had higher intakes compared to adolescents and children. Given the reduced intake in n-3
fatty acids in females compared to males, it is important to consider the potential implications for
pregnancy due to fetal reliance on maternal DHA for brain and retinal development [4]. The sole
source of n-3 fatty acids in breast-fed infants is the mother’s milk [38] and low n-3 polyunsaturated
fatty acid intake during pregnancy and breast-feeding could be a contributing factor to poor infant
neural development [30,32,33]. In the current study, we found significantly lower fish consumption
in pregnant women compared to non-pregnant women of childbearing age, including reduced
consumption of high n-3 fatty acid-containing fish. This may be due in part to concerns about
the effects of mercury present in fish on their pregnancy and fetal development, causing women
to decrease their consumption of fish or avoid it all together. Despite consistent findings of lower
fish intake in pregnant women [21,22], we did not find a significant difference in total EPA, DHA,
and EPA+DHA intake between pregnant women and non-pregnant women between 20–44 years of
age. This may be explained in part by increased EPA/DHA-containing supplement use by pregnant
women (7.3% compared to 0.6% in non-pregnant women of childbearing-age), which is consistent with
our previous findings regarding supplement use [21]. Compared to the recommendations given by
the Workshop of Essentiality of and Recommended Dietary Intake, estimated EPA+DHA intake by
pregnant women in our study was less than one-fifth of the recommended 520 mg/day EPA+DHA
for pregnant and lactating women [25], consistent with our previous studies [21,22]. Together, these
studies indicate that low EPA+DHA is a persistent problem in pregnant women in the US.
Strengths and Limitations
We analyzed a large, representative sample of the US population, stratifying by age, gender,
and pregnancy status. Our EPA+DHA intake findings are based on a 24-h dietary recall method that
is considered sufficient for accurately measuring mean dietary intakes at the population level [39].
However, this may not reflect an individual’s habitual dietary pattern, and a recent study identified
discrepancies in the NHANES dataset with regard to energy intake values within plausible ranges [40].
To reduce the potential effect of this, we limited our study only to participants who reported plausible
caloric intake ranges and excluded adult men with caloric intakes of <800 kcal or >8000 kcal per day
and adult women with caloric intakes of <600 kcal or >6000 kcal per day. Furthermore, in addition to
the 24-h dietary recall analysis, we also included an assessment of fish intake over a 30-day period
that corroborated and expanded upon our overall EPA+DHA intake findings. However, it should also
be noted that assessing n-3 fatty acid intake based on fish intake also has limitations. For instance,
the EPA and DHA of a particular species of fish can differ based on its source, with some species
of farmed fish having substantially lower EPA and DHA than their wild-caught counterparts [41].
Nonetheless, our results are in agreement with other recent investigations, providing consistent
evidence for interpretation [19–21,42]. The cross-sectional nature of NHANES must also be considered
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in the interpretation of our results as we cannot establish any causal relationships related to intake.
The lack of standardized guidelines for sufficient n-3 fatty acid intake also impedes our ability to
draw inferences from the current results. In particular, guidelines that are specific for age, gender,
or vulnerable subgroup populations are limited, and inadequate research into the required levels of
n-3 fatty acids to support specific physiological functions presents a hindrance to developing strong,
evidence-based recommendations. Furthermore, our study does not assess for other factors that may
influence results (e.g., geographic regions, ethnicities, or socioeconomic factors) and these warrant
further consideration in future studies.
5. Conclusions
To our knowledge, this is the first analysis of the 2003–2014 NHANES data to assess for differences
in EPA+DHA intake across the lifespan and between genders. We found that n-3 fatty acid intake
across all age groups was lower than recommended amounts. Within age subgroups, younger
individuals have lower DHA+EPA intake and fish consumption compared to adults and seniors.
Furthermore, women had lower n-3 fatty acid intake compared to men across age groups, with no
difference in EPA+DHA intake between pregnant women and non-pregnant women of childbearing
age. Taken together, these findings demonstrate that low n-3 fatty acid intake is consistent among the
US population and could increase the risk for adverse health outcomes, particularly in vulnerable
populations (e.g., young children and pregnant women).
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